secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caris Life Sciences, Inc. (CAI)
CIK:        0002019410
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0002019410-25-000020
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caris Life Sciences adopts 3% ownership threshold for derivative proceedings
----------------------------------------------------------------------------

- Board approved amendment to bylaws on October 30, 2025 requiring 3% beneficial ownership to institute or maintain a derivative proceeding.
- Threshold applies to any shareholder or group of shareholders acting together under the Texas Business Organizations Code.
- Changes are effective immediately; full text of amended bylaws filed as Exhibit 3.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2019410/000201941025000020/0002019410-25-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2019410/000201941025000020/cai-20251030.htm
  HTML page:      https://secwatch.observer/filing/0002019410-25-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer